We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Supplement Improves Cognitive Benefits in Mouse Model of Alzheimer’s Disease

News   Feb 07, 2018 | By the National Institutes of Health (NIH)

 
Compound Prevents Neurological Damage, Shows Cognitive Benefits in Mouse model of Alzheimer’s Disease

The brains of mouse models treated with the supplement nicotinamide riboside showed reduced tau and less DNA damage than non-treated mice. (Similar to pictured). Credit: National Institutes of Health

 
 
Advertisement
 

RELATED ARTICLES

Sniffing Out Smell: How the Brain Organizes Odor Information

News

A new study describes how relationships between different odors are encoded in the olfactory cortex, the region of brain responsible for processing smell.

READ MORE

Chemo Drug May Be Less Effective in Overweight Women With Breast Cancer

News

Breast cancer patients who are overweight or obese might benefit less from treatment with a common chemotherapy drug, called docetaxel.

READ MORE

Steroids May Offer COVID-19 Treatment Strategy in Patients With Endocrine Disorders

News

According to a new review, people with endocrine disorders may see their condition worsen as a result of COVID-19. The study authors note that mortality was shown to be lower in severely-ill patients with COVID-19 treated with the steroid dexamethasone.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE